Atossa Therapeutics issues Series A/B common stock purchase warrants dated June 12, 2026
Atossa Therapeutics has issued common stock purchase warrants exercisable beginning December 12, 2026, with terms defined in a June 10, 2026 Securities Purchase Agreement. The warrants allow holders to purchase company common stock at specified exercise prices through termination dates based on warrant series.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day